Refractory HIV Associated Kaposi Sarcoma
1 clinical trials · Condition
◉ Watch Refractory HIV Associated Kaposi Sarcoma
| Record | Firm | Date |
|---|---|---|
| Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma (NCT05646082) | Imperial College London | 2023-05-26 |
Track Refractory HIV Associated Kaposi Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.